Covered recipient · General Payments record
JEFFREY CURTIS
Allopathic & Osteopathic Physicians Internal Medicine Rheumatology
A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.
Saved only in this browser. No account or alerts.
General Payments · PY2023 · Entire year
$124,700.66
85 records · 0 disputed
“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”
— Centers for Medicare & Medicaid Services, Open Payments
A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.
These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.
A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.
How these totals are calculated
- This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Methodology & Data — sourcing, labeling, and limitations.
Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗
By nature of payment
PY2023 · entire year · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Consulting Fee | $100,933.90 | 35 |
| Travel and Lodging | $18,734.59 | 22 |
| Education | $3,887.77 | 5 |
| Food and Beverage | $1,144.40 | 23 |
By paying entity
PY2023 · entire year · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ModernaTX, Inc. | $24,194.23 | 16 |
| Amgen Inc. | $16,172.98 | 9 |
| AbbVie Inc. | $15,174.21 | 11 |
| PFIZER INC. | $12,075.00 | 3 |
| GENZYME CORPORATION | $12,053.31 | 3 |
| UCB SA | $10,445.90 | 3 |
| GlaxoSmithKline, LLC. | $10,023.46 | 6 |
| Janssen Biotech, Inc. | $9,241.64 | 11 |
| SANOFI-AVENTIS U.S. LLC | $4,536.00 | 2 |
| Radius Health, Inc. | $3,887.77 | 5 |
| Eli Lilly and Company | $1,600.00 | 1 |
| UCB, Inc. | $1,565.20 | 9 |
| Mylan Inc. | $1,563.00 | 1 |
| Janssen Scientific Affairs, LLC | $1,330.00 | 1 |
| Fresenius Kabi USA, LLC | $650.00 | 1 |
| Cardinal Health 110 LLC | $138.42 | 1 |
| Novartis Pharmaceuticals Corporation | $28.19 | 1 |
| Lilly USA, LLC | $21.35 | 1 |
Page 2 of 2; records 51–85 of 85 matching records. This page contains 35 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.
IndustryPayments · General Payments
JEFFREY CURTIS
NPI 1669415725 · CMS profile ID 211411
Allopathic & Osteopathic Physicians / Internal Medicine / Rheumatology
BIRMINGHAM, AL
A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.
A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.
General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types
Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00
Page 2 of 2; records 51–85 of 85 matching records. This page contains 35 records (maximum 50), not the full filtered export.
Filtered page: https://industrypayments.org/provider/npi-1669415725?year=2023&recipient=provider&page=2#records-h
CMS source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9
Cite these filtered records
The citation includes this program year, filters, data edition, and page of results.
- Plain
- JEFFREY CURTIS, NPI 1669415725, CMS profile ID 211411. General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 2; records 51–85 of 85 matching records. This page contains 35 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1669415725?year=2023&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9.
- APA 7
- IndustryPayments. (2026). JEFFREY CURTIS, NPI 1669415725, CMS profile ID 211411. General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 2; records 51–85 of 85 matching records. This page contains 35 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1669415725?year=2023&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9.
- Bluebook
- JEFFREY CURTIS, NPI 1669415725, CMS profile ID 211411, IndustryPayments, General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 2 of 2; records 51–85 of 85 matching records. This page contains 35 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9. https://industrypayments.org/provider/npi-1669415725?year=2023&recipient=provider&page=2#records-h.
Centers for Medicare & Medicaid Services, Open Payments
Citation formats are provided for reference; check the requirements of your publication.
Payment records · PY2023
Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them
General Payments · PY2023 · Physicians and non-physician practitioners · CMS publication 2026-06-30
85 matching records · $124,700.66 reported total · 0 disputed
Nature of payment: All payment types
Records imported here (UTC).
CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.
Showing records 51–85 of 85.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Publication flags | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|---|
| Amgen Inc. | $2,250.00 | 05/24/2023 | Consulting Fee | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 1019961219 | CMS |
| Fresenius Kabi USA, LLC | $650.00 | 05/15/2023 | Consulting Fee | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 1060083949 | CMS |
| AbbVie Inc. | $5,400.00 | 05/10/2023 | Consulting Fee | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 996562633 | CMS |
| AbbVie Inc. | $51.75 | 05/10/2023 | Travel and Lodging | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 996562635 | CMS |
| Amgen Inc. | $1,740.00 | 05/08/2023 | Consulting Fee | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 1019961225 | CMS |
| Amgen Inc. | $1,740.00 | 05/08/2023 | Consulting Fee | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 1019961229 | CMS |
| AbbVie Inc. | $4,200.00 | 05/04/2023 | Consulting Fee | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 996562629 | CMS |
| AbbVie Inc. | $968.40 | 04/20/2023 | Travel and Lodging | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 996562625 | CMS |
| Eli Lilly and Company | $1,600.00 | 04/20/2023 | Consulting Fee | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 1031623845 | CMS |
| AbbVie Inc. | $254.56 | 04/19/2023 | Travel and Lodging | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 996562613 | CMS |
| AbbVie Inc. | $7.00 | 04/19/2023 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 996562617 | CMS |
| AbbVie Inc. | $80.05 | 04/19/2023 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 996562621 | CMS |
| UCB, Inc. | $3.80 | 04/03/2023 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 1021771567 | CMS |
| UCB, Inc. | $4.05 | 04/03/2023 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 1021771573 | CMS |
| UCB, Inc. | $21.00 | 04/03/2023 | Travel and Lodging | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 1021771577 | CMS |
| UCB, Inc. | $35.00 | 04/03/2023 | Travel and Lodging | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 1021771583 | CMS |
| UCB, Inc. | $3.80 | 04/03/2023 | Food and Beverage | No dispute reported | Delay: No Change: NEW | 06/30/2026 | 1249335086 | CMS |
| UCB, Inc. | $4.05 | 04/03/2023 | Food and Beverage | No dispute reported | Delay: No Change: NEW | 06/30/2026 | 1249335088 | CMS |
| UCB, Inc. | $21.00 | 04/03/2023 | Travel and Lodging | No dispute reported | Delay: No Change: NEW | 06/30/2026 | 1249335090 | CMS |
| UCB, Inc. | $35.00 | 04/03/2023 | Travel and Lodging | No dispute reported | Delay: No Change: NEW | 06/30/2026 | 1249335092 | CMS |
| Radius Health, Inc. | $637.56 | 03/31/2023 | Education | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 1024695139 | CMS |
| GlaxoSmithKline, LLC. | $1,558.37 | 03/24/2023 | Consulting Fee | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 1002784333 | CMS |
| UCB, Inc. | $1,437.50 | 03/20/2023 | Consulting Fee | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 1021771589 | CMS |
| Amgen Inc. | $1,375.00 | 03/17/2023 | Consulting Fee | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 1019961215 | CMS |
| GlaxoSmithKline, LLC. | $118.15 | 03/16/2023 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 1002784343 | CMS |
| GlaxoSmithKline, LLC. | $1,168.77 | 03/15/2023 | Consulting Fee | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 1002784289 | CMS |
| PFIZER INC. | $2,850.00 | 03/13/2023 | Consulting Fee | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 1049626691 | CMS |
| AbbVie Inc. | $1,800.00 | 03/08/2023 | Consulting Fee | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 996562609 | CMS |
| SANOFI-AVENTIS U.S. LLC | $1,620.00 | 02/21/2023 | Consulting Fee | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 1049959161 | CMS |
| UCB SA | $4,660.90 | 02/03/2023 | Consulting Fee | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 1021298285 | CMS |
| GENZYME CORPORATION | $8,645.00 | 01/31/2023 | Consulting Fee | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 1049959253 | CMS |
| Amgen Inc. | $3,025.00 | 01/25/2023 | Consulting Fee | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 1019961211 | CMS |
| Radius Health, Inc. | $70.44 | 01/15/2023 | Education | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 1024695135 | CMS |
| AbbVie Inc. | $600.00 | 01/05/2023 | Consulting Fee | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 996562605 | CMS |
| GlaxoSmithKline, LLC. | $3,914.36 | 01/04/2023 | Consulting Fee | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 1002784323 | CMS |
By program year
All program years on this page · sorted by year
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-06-30
- Program years on this page
- 2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
- Source files
- Dataset page · Bulk file · PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024 , PY2025
- Generated from
- OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.
Research Payments
One row per program year and role, newest year first · amounts for the two roles are never added together
| Program year | Role | Amount | Records |
|---|---|---|---|
| PY2025 | Recipient | $7,670.00 | 4 |
| PY2025 | Principal investigator | $307,173.27 | 6 |
| PY2024 | Recipient | $5,410.00 | 4 |
| PY2024 | Principal investigator | $1,744,059.27 | 9 |
| PY2023 | Recipient | $8,430.00 | 4 |
| PY2023 | Principal investigator | $2,119,701.77 | 7 |
| PY2022 | Recipient | $7,920.00 | 7 |
| PY2022 | Principal investigator | $3,603,745.91 | 12 |
| PY2021 | Recipient | $25,384.21 | 18 |
| PY2021 | Principal investigator | $4,018,081.56 | 14 |
| PY2020 | Recipient | $28,547.06 | 20 |
| PY2020 | Principal investigator | $3,344,667.01 | 29 |
| PY2019 | Recipient | $20,881.83 | 18 |
| PY2019 | Principal investigator | $1,857,005.59 | 29 |
Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.
“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”
— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224
Research Payments records · PY2025
Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them
10 records in PY2025
| Role | Paying entity | Amount | Date | Recipient | Study | Dispute status | Published | Record ID |
|---|---|---|---|---|---|---|---|---|
| Recipient | PFIZER INC. | $3,200.00 | 12/19/2025 | Covered Recipient Physician | TOFACITINIB CLINICAL PUBLICATION PROGRAM | No dispute reported | 06/30/2026 | 1228803364 |
| Recipient | PFIZER INC. | $3,200.00 | 12/01/2025 | Covered Recipient Physician | TOFACITINIB CLINICAL PUBLICATION PROGRAM | No dispute reported | 06/30/2026 | 1228802687 |
| Principal investigator 1 | Amgen Inc. | $2,142.77 | 09/05/2025 | Non-covered Recipient Entity UNIVERSITY OF ALABAMA AT BIRMINGHAM | FDA PMC: Multi year OR of Romosozumab patients relative to CV risk factors in other OP patients | No dispute reported | 06/30/2026 | 1246650190 |
| Principal investigator 1 | Amgen Inc. | $30.50 | 06/16/2025 | Covered Recipient Teaching Hospital University Of Alabama Hospital | Dz outcomes HCRU & cost in TAVNEOS users | No dispute reported | 06/30/2026 | 1246638078 |
| Principal investigator 1 | PFIZER INC. | $85,000.00 | 06/16/2025 | Non-covered Recipient Entity FOUNDATION FOR ADVANCING SCIENCE | IS IL15 RECEPTORALPHAMEDIATED SIGNALING DEFECTIVE IN IN ALOPECIA AREATA AND DOES ITS RESTORATION PROVIDE RELATIVE DISEASE PROTECTION | No dispute reported | 06/30/2026 | 1228846089 |
| Recipient | PFIZER INC. | $940.00 | 06/13/2025 | Covered Recipient Physician | TOFACITINIB CLINICAL PUBLICATION PROGRAM | No dispute reported | 06/30/2026 | 1228838571 |
| Principal investigator 1 | Amgen Inc. | $60,000.00 | 04/01/2025 | Non-covered Recipient Entity FOUNDATION FOR ADVANCING SCIENCETECHNOLOGY EDUCATION AND RESEARCH | Achievement of Disease Remission in pegloticase users | No dispute reported | 06/30/2026 | 1246641591 |
| Principal investigator 1 | E.R. Squibb & Sons, L.L.C. | $85,000.00 | 01/29/2025 | Covered Recipient Teaching Hospital University Of Alabama Hospital | The COvid19 VaccinE Response in Rheumatology patients (COVER) | No dispute reported | 06/30/2026 | 1235999866 |
| Principal investigator 1 | Amgen Inc. | $75,000.00 | 01/28/2025 | Non-covered Recipient Entity FOUNDATION FOR ADVANCING SCIENCETECHNOLOGY EDUCATION AND RESEARCH | Unmet medical need in uncontrolled gout. | No dispute reported | 06/30/2026 | 1246641595 |
| Recipient | PFIZER INC. | $330.00 | 01/13/2025 | Covered Recipient Physician | TOFACITINIB CLINICAL PUBLICATION PROGRAM | No dispute reported | 06/30/2026 | 1228838567 |